TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Verastem Inc (VSTM)

Healthcare Biotechnology
5.70 $
-1.9% vs. previous close
Closing price · As of: 3. Aug 2026

Verastem Inc (VSTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -52 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Cash Flow VSTM
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
-20 -17 -30 -28 -28 -24 -25 -39 -33 -36 -30 -52 -151
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 1.0
1.4 1.5 1.6 1.5 1.9 1.9 2.0 1.8 3.4 2.2 2.0 2.0 9.7
1.4
-1.1 2.5 0.0 -1.5 -11 12 4.6 4.3 8.6 2.9 10 -8.6 13
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.3
14 -70 12 31 29 -0.2 0.2 0.0 0.0 -8.3 -1.3 -16 -26
92
-0.4 -0.2 0.0 32 0.0 0.0 0.0 0.0 0.0
91 -0.9 -0.4 0.8 -0.4 54 0.7 67 79 18 99 29 225
86 -88 -18 3.5 1.0 30 -24 29 47 -27 67 -39 48
-20 -17 -30 -28 -28 -24 -25 -39 -33 -36 -31 -52 -152

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?